These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group]. Appel P, Berger I, Harrer G. Arzneimittelforschung; 1971 Jul; 21(7):1083-6. PubMed ID: 4935400 [No Abstract] [Full Text] [Related]
4. [Clinical observations on the action of the new benzodiazepine, B 5833 (camazepm)]. Visentin B, Mattiuzzi D, Tallone G. Clin Ter; 1974 Mar 31; 69(4):353-9. PubMed ID: 4844933 [No Abstract] [Full Text] [Related]
7. Psychopharmacologic investigation with butriptyline hydrochloride (AY-62014) in patients with various depressive disturbances. Saldaña OH, Hernández J. J Med; 1971 Mar 31; 2(5):309-10. PubMed ID: 4948367 [No Abstract] [Full Text] [Related]
8. [Comparative evaluation of antidepressive-anxiolytic substances, with special references to Doxepin (Sinquan), a diphenylmethane derivative]. Terzani S. Schweiz Arch Neurol Neurochir Psychiatr; 1972 Mar 31; 110(1):169-82. PubMed ID: 5028388 [No Abstract] [Full Text] [Related]
11. [Low doses of noxiptilin in the therapy of depressive states of the involutional, endogenous and neurotic type]. Jacopino GE, Astengo F, Giaretti R, Bertolini S, Castello C, Balestreri R. Clin Ter; 1977 Apr 15; 81(1):19-30. PubMed ID: 577198 [No Abstract] [Full Text] [Related]
14. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls. Wiersum J. Curr Ther Res Clin Exp; 1972 Aug 15; 14(8):442-8. PubMed ID: 4629306 [No Abstract] [Full Text] [Related]